TITLE

Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly

AUTHOR(S)
Penny, Elizabeth S.; Penman, Erica; Price, Janet; Rees, Lesley H.; Sopwith, A.M.; Wass, J.A.H.; Lytras, N.; Besser, G.M.
PUB. DATE
August 1984
SOURCE
British Medical Journal (Clinical Research Edition);8/25/1984, Vol. 289 Issue 6443, p453
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the circulating growth hormone releasing factor (GRF) concentrations in patients with and without acromegaly in Great Britain. Measurement by radioimmunoassay; Evaluation of GRF concentrations in plasma samples;.
ACCESSION #
4971191

 

Related Articles

  • Therapeutic trial of growth hormone releasing factor in HIV patients. Winslow, Dean L. // AIDS Alert;Apr2008, Vol. 23 Issue 4, p45 

    This multicenter, randomized, placebo-controlled trial of a synthetic GHRH analogue, tesamorelin (1-44 amino acids from the amino terminal of GHRH with a trans-3-hexenoyl group added to the amino terminal to increase the half-life over native GHRH), randomized 412 patients (86% male) to daily...

  • Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature. Ramírez, Claudia; Hernández-Ramirez, Laura-Cristina; Espinosa-de-los-Monteros, Ana-Laura; Franco, Juan Manuel; Guinto, Gerardo; Mercado, Moises // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background In more than 98% of cases, acromegaly is due to a GH-secreting pituitary adenoma. The term "ectopic acromegaly" includes neuroendocrine tumors secreting GH releasing hormone (GHRH), usually located in the lungs, thymus and endocrine pancreas. Considerably less frequent are cases of...

  • 1997 Canadian research award for specialty residents in the division of surgery.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS22 

    Presents an abstract of the research manuscript `Overexpression of the growth hormone-releasing hormone gene in acromegaly associated pituitary tumors: An event associated with neo-plastic progression and aggressive behavior,' by K. Thapar, K. Kovacs et al from the University of Toronto.

  • Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Weckbecker, Gisbert; Lewis, Ian; Albert, Rainer; Schmid, Herbert A.; Hoyer, Daniel; Bruns, Christian // Nature Reviews Drug Discovery;Dec2003, Vol. 2 Issue 12, p999 

    Somatostatins - also known as somatotropin-release inhibiting factors (SRIFs) - are a family of cyclopeptides that have broad inhibitory effects on the secretion of hormones such as growth hormone, insulin and glucagon. These effects have formed the basis for the clinical use of SRIF analogues...

  • Ectopic Acromegaly Due to a Pancreatic Neuroendocrine Tumor Producing Growth Hormone-Releasing Hormone. Danielle Weiss; Hannes Vogel; M. Lopes; Steven Chang // Endocrine Practice;Jan2011, Vol. 17 Issue 1, p79 

    Objective: To present a case of acromegaly due to ectopic growth hormone-releasing hormone (GHRH) secretion from a pancreatic neuroendocrine tumor in the context of multiple endocrine neoplasia type 1 (MEN 1).Methods: We describe the clinical, imaging, and pathologic findings of the study...

  • Osteoarticular Changes in Acromegaly. Killinger, Zdenko; Kužma, Martin; Sterančáková, Lenka; Payer, Juraj // International Journal of Endocrinology;2012, p1 

    Acromegaly is caused by hypersecretion of growth hormone (GH) and consequently of insulin-like growth factor-I (IGF-1) due to pituitary tumor. Other causes, such as increased growth-hormone releasing hormone (GHRH) production, ectopic GHRH production, and ectopic GH secretion, are rare. Growth...

  • Acromegaly: Role of Surgery in the Therapeutic Armamentarium. Guinto, Gerardo; Abdo, Miguel; Zepeda, Erick; Arechiga, Norma; Mercado, Moisés // International Journal of Endocrinology;2012, p1 

    Acromegaly is a complex disease that requires the intervention of a multidisciplinary team. The most frequent clinical manifestations are growing of distal parts of the body and some areas of the face. Patients may also present arterial hypertension, diabetes mellitus, colonic polyps,...

  • Ectopic acromegaly due to growth hormone releasing hormone. Ghazi, Ali; Amirbaigloo, Alireza; Dezfooli, Azizollah; Saadat, Navid; Ghazi, Siavash; Pourafkari, Marina; Tirgari, Farrokh; Dhall, Dheepti; Bannykh, Serguei; Melmed, Shlomo; Cooper, Odelia // Endocrine (1355008X);Apr2013, Vol. 43 Issue 2, p293 

    Acromegaly secondary to extra-pituitary tumors secreting growth hormone releasing hormone (GHRH) is rarely encountered. We review the literature on ectopic acromegaly and present the index report of ectopic acromegaly secondary to GHRH secretion from a mediastinal paraganglioma. Clinical and...

  • Height Gain at Adult-Height Age in 184 Short Patients Treated with Growth Hormone from Prepubertal Age to Near Adult-Height Age is Not Related to GH Secretory Status at GH Therapy Onset. Carrascosa, a.; audí, L.; Fernández-Cancio, M.; Yeste, D.; Gussinye, M.; Campos, a.; albisu, M.a.; Clemente, M.; Bel, J.; Nosás, R.; Rabanal, M.; del Pozo, C.; Gómez, J.M.; Mesa, J. // Hormone Research in Paediatrics;Apr2013, Vol. 79 Issue 3, p145 

    Background: GH release after stimuli classifies short children as severe idiopathic isolated GH deficiency (IIGHD), mild IIGHD, dissociated GH release (DGHR) and normal GH release (NGHR) and anthropometric birth data as adequate for gestational age (AGA) or small for gestational age (SGA). GH...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics